Contemporary diagnosis of ATRT relies on demonstrating biallelic inactivation of SMARCB1 and less commonly, other SWI/SNF complex genes with malignant transformation driven by disruption of chromatin remodeling. The gene discussed is SMARCB1; the disease is atypical teratoid rhabdoid tumor.